One pangenome to bind them all - Nature Biotechnology

Brasil Notícia Notícia

One pangenome to bind them all - Nature Biotechnology
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 63%

One pangenome to bind them all The pangenome provides a first glimpse of the scope of human genetic diversity. But its routine adoption into research and clinical practice faces several challenges

and continuous long-read sequencing supplemented with Oxford Nanopore Technologies ultralong sequencing to tile across repetitive sequences and build a near-complete genome through graph assembly. The published genome has one error every 10.5 Mb ; it has since beenHPRC aims to assemble 700 reference-quality haplotypes from 350 individuals at a quality similar to that of the recent T2T assembly, improving representation of genomic and geographic diversity.

The result — two decades after the first draft — is a near-complete human genome reference. This is particularly important for clinical genetics, where the pangenome can produce fewer ambiguous mappings, provide more accurate analyses of copy number variation, and resolve multiallelic regions of high clinical importance locus) that fail to be captured in the existing linear reference.

But routine clinical implementation of a human pangenome reference will require new bioinformatics methods capable of querying and operating on it. Unlike the gapless T2T genome, which has a single haplotype, the technology for querying pangenomes with gapless diploid assemblies remains a work in progress.

And most clinical genetics laboratories are unprepared: going from raw sequencing reads to a short-list of variants of clinical importance involves multiple computational tools maintained by different research groups or organizations, as well as queries to external databases like

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

NatureBiotech /  🏆 231. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

DeepConsensus improves the accuracy of sequences with a gap-aware sequence transformer - Nature BiotechnologyDeepConsensus improves the accuracy of sequences with a gap-aware sequence transformer - Nature BiotechnologyDeepConsensus improves the accuracy of sequences with a gap-aware sequence transformer
Consulte Mais informação »

Decentralized investor communities gain traction in biotech - Nature BiotechnologyDecentralized investor communities gain traction in biotech - Nature BiotechnologyDespite its checkered reputation, cryptocurrency is being considered by a handful of academics as a means to funnel funds into translational research. Is the trend likely to spread? Laura DeFrancesco and Ariel Klevecz investigate.
Consulte Mais informação »

Will we ever know the true nature of 'Oumuamua, the first interstellar visitor?Will we ever know the true nature of 'Oumuamua, the first interstellar visitor?'Oumuamua is perhaps the strangest object we have ever seen inside the solar system.
Consulte Mais informação »

Market Wrap: Bitcoin's Price Rises Amid UncertaintyMarket Wrap: Bitcoin's Price Rises Amid UncertaintyMARKET WRAP: BTC traded higher, while markets remain uncertain. GWilliamsJr_CMT and _jocelynyang_ reports
Consulte Mais informação »

Massachusetts biotech companies thrive during pandemic, report findsMassachusetts biotech companies thrive during pandemic, report findsThe Massachusetts biotechnology industry appears to be thriving, despite a national stock slump and the ongoing COVID pandemic:
Consulte Mais informação »



Render Time: 2025-03-11 21:55:25